Because there is a lack of comparative studies assessing drug-coated balloon (DCB) and drug-eluting stent (DES) outcomes with respect to intraluminal (IL) and subintimal (SI) approaches in femoropopliteal (FP) total occlusive lesions, we compared the outcomes between DCB (including bailout stenting) and DES treatments for this lesion. A total of 487 limbs (434 patients) were divided into the IL (n = 344, DCB: n = 268, DES: n = 76) and SI (n = 143, DCB: n = 83, DES: n = 60) approach groups. The primary outcome was a major adverse limb event (MALE), defined as above-ankle amputation or repeat revascularization of the index limb. Secondary outcomes included clinically driven target lesion revascularization (TLR), loss of clinical patency, and all-cause death. After adjustment, in each IL and SI approach, the 2-year rates of MALE (p = 0.180 and p = 0.236, respectively), TLR, loss of clinical patency, and all-cause death were similar between the DCB and DES groups. In the DCB and DES groups, both primary and secondary outcomes were similar between the IL and SI approaches. DCB and DES strategies for patients presenting with FP total occlusive lesions demonstrated similar outcomes regardless of the IL or SI approach.Clinical Trial Registration: NCT02748226.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11387717 | PMC |
http://dx.doi.org/10.1038/s41598-024-71745-0 | DOI Listing |
Catheter Cardiovasc Interv
December 2024
Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
There is a growing trend of patients with significant comorbidities among those referred for percutaneous coronary intervention (PCI). Consequently, the number of patients undergoing complex high risk indicated PCI (CHIP) is rising. CHIP patients frequently present with factors predisposing to extensive drug-eluting stent (DES) implantation, such as bifurcation and/or heavily calcified coronary lesions, which exposes them to the risks associated with an increased stent burden.
View Article and Find Full Text PDFCureus
November 2024
Cardiology, Lebanese American University School of Medicine, Beirut, LBN.
BMC Cardiovasc Disord
December 2024
Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.
Catheter Cardiovasc Interv
December 2024
Terrence Donnelly Heart Centre, St Michaels Hospital, Toronto, Ontario, Canada.
Front Cardiovasc Med
November 2024
Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!